SUPC-05 FRAILTY AND SARCOPENIA IN SPINAL ONCOLOGY: A SYSTEMATIC REVIEW
Eli Johnson, M D Maclean, Antoinette J. Charles, Miltiadis Georgiopoulos et autres
Abstract Introduction Metastatic spine disease (MSD) is increasingly common as new targeted therapies allow our patients to live to an elderly age, many with medical comorbidities. Frailty and sarcopenia are known predictors of worse surgical outcomes in degenerative and deformity-related populations, however, …
us, ca, de, sg, ch, au (code pays fourni par la source)
0 citations
Neuro-Oncology Advances